Not yet available, we are working hard on this format.
View the NAD+ penNAD+ 300 mg peptide pen
Three hundred milligrams of the coenzyme, not a peptide, as our own pages insist, in the pre-filled format, for the delivery-question side of NAD+ research.
- ISO-certified laboratory
- COA per batch, ≥99% HPLC
- Discreet dispatch within 24 h
- Research use only
The coenzyme, delivered directly
NAD+ is nicotinamide adenine dinucleotide: the electron carrier every cell runs on, consumed by the sirtuin and PARP enzyme families, declining with age in ways research is still interpreting. Not a peptide, a point the NAD+ compound page makes rather than hides.
The 300 mg pen serves protocols investigating direct administration, one answer to the delivery question that defines this molecule’s research. The nasal spray on this shelf is the other; the compound page frames the choice.
| Compound | NAD+ (dinucleotide) |
| Content | 300 mg, pre-filled |
| Class | Coenzyme, not a peptide |
| Purity | ≥ 99% (HPLC) |
| Consumed by | Sirtuins, PARPs |
| Storage | Refrigerate; protect from light |
| Category | Research use only |
Precursor research (NR, NMN) is a different route entirely, we stock neither, and say so.
Before the NAD+ 300 mg peptide pen reaches the bench
Large-content cartridge, standard cold-chain rules.
What the forums promise, and what the bench asks
What the forums promise NAD+, and what a controlled bench actually asks of it.
Few molecules carry more forum enthusiasm than NAD+, much of it on the hope that refilling an age-declining coenzyme must help the cell. Controlled work is more careful. NAD+ is nicotinamide adenine dinucleotide, the electron carrier that sirtuin and PARP enzymes consume, and the open question is not whether it matters but whether giving it directly changes anything measurable in the cell, a question the NAD+ literature on PubMed is still working through. That gap between story and shown effect is what the bench exists to close.
Translated to the bench, the live question about NAD+ is delivery, and the three-hundred-milligram pen is one answer to it. Researchers who buy nad+ pen material are usually testing direct administration against other routes, the nasal spray shelf among them, not assuming any of them works. The catalogue never hides what this is: a coenzyme, a dinucleotide, not a peptide. The forum treats that distinction as a technicality; the literature treats it as the starting point.
The fridge, and the calendar
A large cartridge of a light-sensitive coenzyme rewards a strict storage rhythm.
Three hundred milligrams is a lot of coenzyme to keep intact, and NAD+ is less forgiving in storage than its plain appearance suggests. Keep the pen cold, and keep it dark: the facts panel lists light protection deliberately, because the dinucleotide degrades under exposure a sturdier compound would shrug off. Between sessions it belongs in the refrigerator, capped and away from the door. A coenzyme studied for its redox role deserves storage that will not quietly oxidise what you measure.
Mark the date of first use on the barrel, and let that mark govern how long the cartridge stays in service. A large fill is an asset only while the contents remain what the certificate described; a pen left warm or bright for a week is no longer that. On arrival, treat the cold-chain packaging as part of the product and refrigerate the pen first. For a molecule whose whole premise is direct delivery, spoilage in storage ends the experiment before it starts.
Routes and neighbours
The spray answer to the same delivery question, and the shelf’s actual peptide.
The science behind NAD+
Classification first, then context.
Questions about the NAD+ 300 mg peptide pen
The coenzyme questions.



